Arbutus Biopharma Corporation Share Price

Arbutus Biopharma Corporation Share Price

NASDAQ: ABUS | Small Cap
$4.06
+$0.02 (0.62%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Arbutus Biopharma Corporation Stock Performance

Open
$4.05
Prev. Close
$4.04
Circuit Range
N/A
Day Range
$3.97 - $4.09
Year Range
$3.56 - $5.38
Volume
2,02,612
Average Traded
$4.03

Arbutus Biopharma Corporation Share Price Today

As of 18 November 2026, Arbutus Biopharma Corporation's share price is $4.06. The stock opened at $4.05, compared to its previous close of $4.04. During today's trading session, Arbutus Biopharma Corporation's share price traded between $3.97 and $4.09, with an average price of $4.03. Over the past 52 weeks, the stock has recorded a high of $5.38 and a low of $3.56. In terms of performance, Arbutus Biopharma Corporation's share price has declined by 10.77% over the last six months and is down 7.73% on a year-on-year basis.

Arbutus Biopharma Corporation Share Price Chart

Line chart of the Arbutus Biopharma Corporation price trend over the selected period. The price rose overall, ranging from 3.97 to 4.08, ending at 4.05.
$3.97$4.09
L
Show Current Price
H

Arbutus Biopharma Corporation Stock Fundamentals & Key Indicators

Market Cap
$777.89M
PE Ratio (TTM)
2.82
Dividend Yield
0.00%
EPS (TTM)
$1.43
Revenue (TTM)
$14.08B
Return On Equity (TTM)
256.41%
Profit Margin
-237.93%
Debt to Equity
0.03
Quarterly Earnings Growth YoY
1672.34%

Arbutus Biopharma Corporation Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.05$179.13$1.01$0.30
Net Profit-$3.76$169.70-$5.19$59.12
Net Profit Margin-358.10%94.74%-513.86%19706.67%
Income ChangeN/A4613.30%-103.06%1239.11%

Arbutus Biopharma Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$39.02$18.14$6.17$14.08
Net Profit-$69.46-$72.85-$69.92-$33.50
Net Profit Margin-178.01%-401.60%-1133.23%-237.93%
Income ChangeN/A-4.88%4.02%52.09%

About Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Arbutus Biopharma Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.27
$4.07
-3.44%
Oct 2026
$4.76
$4.21
-11.92%
Sep 2026
$5.09
$4.78
-7.36%
Aug 2026
$4.34
$5.16
+18.62%
Jul 2026
$4.84
$4.35
-9.38%
Jun 2026
$4.47
$4.80
+5.49%
May 2026
$4.17
$4.55
+8.08%
Apr 2026
$4.53
$4.21
-6.24%
Mar 2026
$4.55
$4.49
-3.65%
Feb 2026
$4.09
$4.66
+12.56%
Jan 2026
$4.84
$4.14
-14.11%
Dec 2025
$4.31
$4.82
+9.55%

ABUS Share Price FAQs